WR
EW icon

WD Rutherford’s Edwards Lifesciences EW Stock Holding History

WD Rutherford’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,303
Closed -$282K – 75
2025
Q4 		$282K Hold
3,303
– – 0.12% 72
2025
Q3 		$257K Sell
3,303
-7
-0.2% -$547 0.11% 69
2025
Q2 		$259K Sell
3,310
-1,475
-31% -$110K 0.12% 66
2025
Q1 		$339K Sell
4,785
-4,697
-50% -$336K 0.18% 67
2024
Q4 		$702K Sell
9,482
-8,893
-48% -$622K 0.33% 58
2024
Q3 		$1.21M Sell
18,375
-22,745
-55% -$1.65M 0.59% 52
2024
Q2 		$3.8M Buy
41,120
+420
+1% +$37.2K 1.91% 18
2024
Q1 		$3.89M Buy
40,700
+1,030
+3% +$86.5K 2.01% 20
2023
Q4 		$2.98M Sell
39,670
-395
-1% -$27.5K 1.73% 29
2023
Q3 		$2.78M Sell
40,065
-3,700
-8% -$297K 1.9% 23
2023
Q2 		$4.13M Sell
43,765
-170
-0.4% -$14.8K 2.64% 9
2023
Q1 		$3.63M Sell
43,935
-115
-0.3% -$9.04K 2.56% 15
2022
Q4 		$3.31M Sell
44,050
-935
-2% -$72.1K 2.6% 12
2022
Q3 		$3.72M Sell
44,985
-1,315
-3% -$127K 2.98% 6
2022
Q2 		$4.4M Sell
46,300
-20
-0% -$2.07K 3.4% 6
2022
Q1 		$5.45M Sell
46,320
-115
-0.2% -$12.9K 3.12% 6
2021
Q4 		$6.02M Sell
46,435
-740
-2% -$86.3K 3.05% 6
2021
Q3 		$5.34M Sell
47,175
-130
-0.3% -$14.8K 2.9% 6
2021
Q2 		$4.9M Buy
47,305
+130
+0.3% +$12.3K 2.73% 8
2021
Q1 		$3.95M Sell
47,175
-665
-1% -$56.2K 2.45% 15
2020
Q4 		$4.36M Buy
+47,840
New +$3.97M 2.76% 14

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

WD Rutherford's EW Position: Q1 2026 in Review

WD Rutherford sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 3,303 shares — an estimated $282K sold.

WD Rutherford first reported a position in EW in Q4 2020 and held it in 21 quarters. The position peaked at $6.02M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • WD Rutherford reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • WD Rutherford sold 3,303 Edwards Lifesciences shares in Q1 2026, an estimated $282K.
  • WD Rutherford first reported a position in Edwards Lifesciences in Q4 2020 and held it in 21 quarters.
  • WD Rutherford's Edwards Lifesciences position peaked at $6.02M in Q4 2021.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on WD Rutherford's 13F filing for Q1 2026, filed 24 Apr 2026.